- Home
- WMB vs BDX Comparison
WMB vs BDX Comparison
Compare WMB & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMB
- BDX
- Stock Information
- Founded
- WMB 1908
- BDX 1897
- Country
- WMB United States
- BDX United States
- Employees
- WMB N/A
- BDX N/A
- Industry
- WMB Natural Gas Distribution
- BDX Medical/Dental Instruments
- Sector
- WMB Utilities
- BDX Health Care
- Exchange
- WMB Nasdaq
- BDX Nasdaq
- Market Cap
- WMB 72.8B
- BDX 64.9B
- IPO Year
- WMB N/A
- BDX 1962
- Fundamental
- Price
- WMB $60.22
- BDX $227.24
- Analyst Decision
- WMB Buy
- BDX Strong Buy
- Analyst Count
- WMB 19
- BDX 7
- Target Price
- WMB $54.71
- BDX $278.29
- AVG Volume (30 Days)
- WMB 7.5M
- BDX 2.0M
- Earning Date
- WMB 05-05-2025
- BDX 05-01-2025
- Dividend Yield
- WMB 3.35%
- BDX 1.82%
- EPS Growth
- WMB N/A
- BDX 41.25
- EPS
- WMB 1.82
- BDX 5.94
- Revenue
- WMB $10,753,000,000.00
- BDX $20,640,000,000.00
- Revenue This Year
- WMB $9.96
- BDX $9.27
- Revenue Next Year
- WMB $8.36
- BDX $4.98
- P/E Ratio
- WMB $32.82
- BDX $38.55
- Revenue Growth
- WMB 8.06
- BDX 5.89
- 52 Week Low
- WMB $37.18
- BDX $218.75
- 52 Week High
- WMB $61.67
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- WMB 59.26
- BDX 45.11
- Support Level
- WMB $58.60
- BDX $225.12
- Resistance Level
- WMB $61.67
- BDX $229.80
- Average True Range (ATR)
- WMB 1.20
- BDX 3.67
- MACD
- WMB 0.12
- BDX 0.08
- Stochastic Oscillator
- WMB 70.55
- BDX 38.59
Stock Price Comparison Chart: WMB vs BDX
About WMB Williams Companies Inc. (The)
Williams Companies is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.